Endocrinology Network Newsletter

To view this email as a web page, click here.

Teplizumab Delays Type 1 Diabetes Onset

Patients who are at high-risk of developing type 1 diabetes may be able to delay the progression of the condition with teplizumab treatment, a new study shows.

Omega-3 Supplement Lowers Risk of Cardiovascular Death Study Shows

The omega-3 fatty acid icosapent ethyl lowered the risk of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization or unstable angina by as much as 25 percent in a group of patients enrolled in a five-year clinical trial, according to researchers reporting in the Jan. 9 issue of the New England Journal of Medicine.

• Stroke Survival Much Improved Since 2000

• Image IQ: Smooth papules on the face

• Dementia Tied to Late-in-Life Weight Gain and Loss

• Treatment Delays Onset of Diabetes in At-Risk Populations

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.